{"id":"W2982882356","doi":"10.25251/skin.3.supp.36","title":"Long-Term Efficacy of Certolizumab Pegol Dosed at 400 mg Every Two Weeks in Patients with Plaque Psoriasis: Pooled 128-Week Data from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)","year":2019,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriasis; Plaque psoriasis; Term (time); Internal medicine; Gastroenterology; Dermatology; Adalimumab; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009699291,0.0004541295,0.001817219,0.0003252046,0.0001157029,0.00001261349,0.0008514181,0.0002166719,0.00130389],"category_scores_gemma":[0.000552984,0.00024429,0.0001407864,0.0002246926,0.0003412187,0.0001829443,0.0002025845,0.0004634489,0.00005133327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001258809,"about_ca_system_score_gemma":0.0001754954,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003349828,"about_ca_topic_score_gemma":0.0002853623,"domain_scores_codex":[0.9958695,0.001426923,0.001561024,0.0003929341,0.0002922843,0.0004573942],"domain_scores_gemma":[0.9938533,0.003175083,0.001712295,0.0009664126,0.000189224,0.0001036732],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3787509,0.00622211,0.3062332,0.0001878332,0.0120786,0.003241488,0.009118052,0.00008561026,0.1484871,0.0000174079,0.004854559,0.1307231],"study_design_scores_gemma":[0.5840867,0.02919036,0.3166466,0.004078182,0.0143243,0.01942904,0.001281045,0.00004995445,0.02789866,0.0002615584,0.001452719,0.001300818],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893037,0.007327633,0.0000221322,0.0005762492,0.001398813,0.0008893598,0.0003789561,0.00001379991,0.00008933621],"genre_scores_gemma":[0.9977297,0.0009610716,0.00003788884,0.0000698373,0.0003480079,0.000003115985,0.0005298306,0.00004248911,0.0002780367],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2053358,"threshold_uncertainty_score":0.9996091,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02978723977001265,"score_gpt":0.2982399611446154,"score_spread":0.2684527213746028,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}